#MedicalDataVision

The total number of outstanding shares will decrease by 37,856,768 shares due to the share consolidation, effective date April 28, 2026. Delisting scheduled for April 24, 2026.

On May 11, 2026, Medical Data Vision Co., Ltd. will issue 1 Class A preferred share by third-party allotment to Nippon Life Insurance Company at 17,249,077,446 yen, and simultaneously reduce capital stock and capital surplus to secure funds for share buyback.

Nippon Life Insurance Company holds 53.05% of voting rights and plans to make a full subsidiary. SBI Holdings plans to acquire its 38.32% shareholding as treasury stock.

Following the acquisition of 52.34% of the Company's shares by the tender offeror, delisting is scheduled on April 24, 2026. The stock consolidation will merge 7,253,607 shares into 2 shares, reducing the number of issued shares by 37,856,768 to 10 shares.

Medical Data Vision Co., Ltd. announced plans to cancel 2,170,748 shares of treasury stock (approximately 5.42% of total outstanding shares) on April 27, 2026.

Recorded an extraordinary loss of 290 million yen due to a decline in the market value of investment securities in the Q4 consolidated accounting period of the fiscal year ending December 2025, reflected in the financial summary.

Consolidated net sales for the fiscal year ending December 2025 amounted to 6,539,159 thousand yen (10.7% YoY increase), operating income was 349,464 thousand yen, and net income attributable to owners of parent was 280,242 thousand yen. Earnings guidance for the fiscal year ending December 2026 is not provided due to delisting planned following a tender offer.

For the fiscal year ending December 2025, net sales were 6,539 million yen, up 10.7% year-over-year (YoY). Operating income stood at 349 million yen, and net income attributable to owners of parent was 280 million yen.

Nippon Life Insurance Company submitted a correction to the tender offer notification for shares of Medical Data Vision Co., Ltd. to the Kanto Local Finance Bureau Director on January 19, 2026, and made partial corrections to the tender offer commencement announcement.